Seonix Bio
1 known investors
Seonix Bio provides genetic risk score testing services for glaucoma and age-related macular degeneration (AMD), using a saliva-based test to predict a patient's disease risk. Its services are offered to health professionals, patients, and pharmaceutical/academic research collaborators, and are available in Australia, New Zealand, and the US.
BiotechDigital HealthHealthtech
Investors · 1
Frequently asked questions
- What does Seonix Bio do?
- Seonix Bio provides genetic risk score testing services for glaucoma and age-related macular degeneration (AMD), using a saliva-based test to predict a patient's disease risk. Its services are offered to health professionals, patients, and pharmaceutical/academic research collaborators, and are available in Australia, New Zealand, and the US.
- Who are Seonix Bio's investors?
- Seonix Bio's investors include South Australian Venture Capital Fund.